News

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

Disney’s research has changed how scientists approach so-called “undruggable” diseases.

Predictors of future diabetes and cardiovascular disease for a person with obesity can be found among their body's metabolites.

New understanding of cell biology could give scientists a potential way to tackle cancer cells. 

Researchers identify the protein responsible for allodynia, a kind of pain that follows gentle touch.

Founding members will help guide academic, scientific and business strategies.

Lorraine S. Evangelista, PhD, RN, has joined the Scripps Research Translational Institute as associate scientific director for the All of Us Research Program’s Participant Center.

Researchers investigate the potential of such platforms for leveraging expert medical knowledge for patient care around the world.

Gross is widely recognized for his contributions to number theory and was named a MacArthur Fellow in 1986.

"The NCI expects big things from us, and we embrace that challenge," Cravatt says.

The results suggest that healthy growth and development of brain cells and brain circuits depends not just upon specific proteins but also upon specific long noncoding RNAs

“I call the molecule a ‘wolf in sheep’s clothing,’ ” says Namir Shaabani, PhD.

Calibr scientists build and deploy new ReFRAME drug collection to find potential therapies against HIV, tuberculosis and parasites that causes severe illness in children.

The recognition reflects Havran’s skills in encouraging trainees to find their place in the research world

The award will support new research into how to design drugs to target cancer cells.

Thomas Kodadek, PhD, will lead the project to make drug development more efficient and less expensive.

In addition to his legacy in advancing cancer therapeutics, Scripps Research scientists know him as a determined scientist and skilled mentor.

A molecule in hoppy beers, like IPAs, appears to fuel weight loss and have benefits for type 2 diabetes in mice. But how?

A new four-year, $3 million grant will enable scientists to advance compounds that may protect neurons in diseases including Parkinson’s, ALS, Alzheimer’s and Creutzfeldt-Jakob disease.

“This would be the first compound to directly target the motivational power of craving triggers.”

"In an age where scientific results are being constantly questioned, open data has become an essential part the discovery process."

“This is like understanding how to kill five or six birds with one stone,” says Erica Ollmann Saphire, PhD, professor at Scripps Research.

The findings suggest these vaccines could increase chances of recovery in cases where a drug therapy alone is not working.

"Pregnant women are curious about their health. They want to understand what is normal for women like them..."